Everest Re Group Ltd. (0U96)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 389.73 |
|---|---|
| 52-week range | 296.42 – 402.03 |
| Return, 1 month / 3 months | +3.8% / +3.3% |
| Return, 1 year / 3 years | +13.2% / +10.3% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 24.4% |
| Worst drawdown (1 year) | -12.5% |
| Average daily value traded | 0.09M USD |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Everest Re Group is a reinsurance and insurance holding company based in Bermuda. Through its subsidiaries, it provides property and casualty reinsurance to insurers and also offers specialty insurance products to businesses and other customers. Its operations serve clients in markets around the world, covering risks such as catastrophe losses and other large or unusual exposures that insurers and companies seek to transfer.
On this site Everest Re Group Ltd. appears as a stock on the London Exchange (UK), code 0U96, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Everest Re Group Ltd. (0U96) trades on the London Exchange in UK. It last closed at USD 389.73 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 611 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.2% and over the last three months it rose 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.2% | ||
| From 52-week high | -2.0% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.3% | ||
| 6-month return | 13.0% | ||
| 12-month return, skipping the last month | 9.0% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.5% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +3.8% |
| 3 months | +3.3% |
| 6 months | +13.0% |
| 1 year | +13.2% |
| 3 years | +10.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 372.21 / 347.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Sep 2026 | USD 2.0000 |
| 11 Jun 2026 | USD 2.0000 |
| 12 Mar 2026 | USD 2.0000 |
| 25 Nov 2025 | USD 2.0000 |
| 3 Sep 2025 | USD 2.0000 |
| 27 May 2025 | USD 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.